NEJM· Emanuel Della-Torre Matthew C. Baker Wen Zhang Cory A. Perugino Guy Katz Yoshiya Tanaka Arezou Khosroshahi Alexander Kleger Nicolas Schleinitz Fernando Martinez-Valle Hendrik Schulze-Koops Shingo Nakayamada Vinciane Rebours Kazuichi Okazaki Lingli Dong Mollie Carruthers Luke Y.C. Chen Luca Frulloni Alireza Meysami Hiroki Takahashi Mitsuhiro Kawano Yanying Liu Takako Saeki Mikael Ebbo Tobias Alexander Andrés González García Omer Karadag Maria Maślińska Shauna M. Quinn Allen Poma Audrey Wells Thomas J. Greene John H. Stone and Emma L. Culverthe INDIGO Trial Investigators*·· 2026-06-02评分21
Obexelimab 治疗 IgG4 相关疾病
Obexelimab for the Treatment of IgG4-Related Disease
导读
Obexelimab 在 IgG4 相关疾病患者中表现出临床疗效和可接受的安全性。一项纳入 45 名患者的研究显示，治疗组 IgG4-RD 应答指数较基线显著改善。该结果支持进一步评估 obexelimab 在这一自身免疫性疾病中的治疗潜力。
来源：NEJM · nejm.org